Onco360(R) Has Been Selected as a Specialty Pharmacy Partner for LYNOZYFIC(TM) (linvoseltamab-gcpt) GlobeNewswire August 04, 2025 LOUISVILLE, Ky., Aug. 04, 2025 (GLOBE NEWSWIRE) — Onco360(R), the nation's leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by Regeneron Pharmaceuticals for Lynozyfic(TM) (linvoseltamab-gcpt), which has been has granted accelerated approval by the Food […]

Stride, Inc. Signs Multi-District Agreements to Operate K12-Powered Online School in New Mexico GlobeNewswire August 04, 2025 RESTON, VA, Aug. 04, 2025 (GLOBE NEWSWIRE) — Stride, Inc. (NYSE: LRN) has now partnered with Chama Valley Independent Schools and Santa Rosa Consolidated Schools, to operate Destinations Career Academy of New Mexico (NMDCA), one of its K12-powered

Primary Care Physician Use of Counterpart Assistant Technology Linked to Better Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease GlobeNewswire August 04, 2025 New whitepaper shows that a relationship with a primary care physician (“PCP”) who uses Counterpart Assistant is correlated with more frequent Chronic Obstructive Pulmonary Disease (“COPD”) diagnosis, increased specialty care, and

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire August 04, 2025 SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company

Bit Origin Announces Completion of Share Capital Reduction GlobeNewswire August 04, 2025 SINGAPORE, Aug. 04, 2025 (GLOBE NEWSWIRE) — Bit Origin Ltd (NASDAQ: BTOG) (“Bit Origin” or the “Company”) today announced that it has completed a reduction of its issued share capital, following the approval by its shareholders and subsequent confirmation by the Grand Court

Shareholders that lost money on Rocket Pharmaceuticals, Inc.(RCKT) Urged to Join Class Action – Contact The Gross Law Firm to Learn More GlobeNewswire August 04, 2025 NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT). Shareholders who purchased shares of

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference GlobeNewswire August 04, 2025 MALVERN, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the

Rubico Announces Commencement of Trading on the Nasdaq Capital Market GlobeNewswire August 04, 2025 ATHENS, Greece, Aug. 04, 2025 (GLOBE NEWSWIRE) — Rubico Inc. (the “Company” or “Rubico”) (Nasdaq: RUBI) announced today that it has completed its spin-off from Tops Ships Inc. effective August 1, 2025. The Company's shares have commenced trading as of today,

Unitil Reports Second Quarter Earnings GlobeNewswire August 04, 2025 HAMPTON, N.H., Aug. 04, 2025 (GLOBE NEWSWIRE) — Unitil Corporation (NYSE: UTL) (unitil.com) today announced Net Income of $4.0 million, or $0.25 in Earnings Per Share (EPS) for the second quarter of 2025, a decrease of $0.3 million in Net Income, or $0.02 in EPS, compared

Gentherm Announces Participation in J.P. Morgan Auto Conference and Seaport Annual Summer Investor Conference GlobeNewswire August 04, 2025 NOVI, Mich., Aug. 04, 2025 (GLOBE NEWSWIRE) — Gentherm (NASDAQ: THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced that it is scheduled to participate in the following upcoming investor events